Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
This Is the Best Pharma Stock to Invest $1,000 in Right Now
09:00am, Sunday, 29'th Sep 2024
Eli Lilly is making massive investments in manufacturing -- a key challenge now. The point of those investments is to produce enough of its drugs to meet demand.
Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
10:00am, Saturday, 28'th Sep 2024
Eli Lilly and Novo Nordisk are spending billions to find new cardiometabolic drugs. Both companies are interested in the possibilities of genetic medicines.
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
05:45am, Saturday, 28'th Sep 2024
Eli Lilly is pretty close to a $1 trillion valuation. Its lineup and pipeline will support strong growth through 2030.
Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever
05:15am, Saturday, 28'th Sep 2024
Certain economic sectors tend to be more resilient in an uncertain macroeconomic climate. Pharmaceutical giant Eli Lilly owns a portfolio of mainstay and emerging blockbuster drugs.
AVGO Does the "Same Thing" NVDA Does, Trading MSTX & LLY
04:39pm, Friday, 27'th Sep 2024
Sylvia Jablonski, CEO of Defiance ETFs, talks about the Defiance Daily Target ETF (MSTX) that began public trading last month. She talks about why it's "a bang for your buck" for tactical traders.
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
03:50am, Friday, 27'th Sep 2024
Eli Lilly's two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition.
Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Thursday, 26'th Sep 2024
Eli Lilly (LLY) closed the most recent trading day at $909.32, moving -1.65% from the previous trading session.
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
10:41am, Thursday, 26'th Sep 2024
Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.
Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?
10:35am, Thursday, 26'th Sep 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
06:01pm, Wednesday, 25'th Sep 2024
Eli Lilly And Co LLY is one of several companies benefitting from demand for weight loss drugs. The company is also seeing competition in the market including knockoff drugs that it said could be unsa
LLY, NVO & Mag 7: Stocks to Watch After Fed's Rate Cut
12:58pm, Wednesday, 25'th Sep 2024
Steven E. Orr says people are getting healthier, and the accessibility of weight loss drugs from companies like Eli Lilly (LLY) and Novo Nordisk (NVO) make them attractive for investors. However, he w
Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
12:46pm, Wednesday, 25'th Sep 2024
Japan is the second major market where LLY's Kisunla has been approved. The drug was first approved in the United States in July 2024.
Why This Stock Could Be the Nvidia of Healthcare
07:30am, Wednesday, 25'th Sep 2024
Artificial intelligence offers not only huge opportunities in technology but also in healthcare. Novo Nordisk and Hippocratic AI are both striving to developing new pathways.
Monthly EGBLYSS maintenance dosing sustained clear or almost-clear skin for up to three years in the vast majority of ADvocate 1 and 2 responders Nearly 87 percent of patients taking EBGLYSS did not
GLP-1 demand is going to remain higher than supply for foreseeable future, says BMO's Evan Seigerman
05:59pm, Tuesday, 24'th Sep 2024
Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's CEO and the demand for weight-loss drugs.
